PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.290
+0.050 (4.03%)
At close: Sep 4, 2026, 4:00 PM EDT
1.240
-0.050 (-3.88%)
After-hours: Sep 4, 2026, 4:16 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $97.41 million as of September 4, 2026. Its market cap has increased by 18.60% in one year.
Market Cap
97.41M
Enterprise Value
18.20M
1-Year Change
18.60%
Ranking
Category
Stock Price
$1.29
ChartMarket Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $97.41M, a decrease of -93.96%. That is a compound annual growth rate of -37.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 97.41M | 46.46% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 99.85M |
| Polaryx Therapeutics | 99.19M |
| Atara Biotherapeutics | 95.66M |
| Kalaris Therapeutics | 93.79M |
| Pelthos Therapeutics | 93.26M |
| Verrica Pharmaceuticals | 92.08M |
| ImmuCell | 90.82M |
| Fortress Biotech | 90.38M |